SOX2 and esophageal squamous cell carcinoma: In the past, SOX2 was identified as a novel lineage survival oncogene in lung and esophageal SCC [1], and numerous experimental data support the assumption that SOX2 promotes cell motility, proliferation and invasive capacity of cancer cells [10], [11], [12], [13].